Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3805767 A
Publication typeGrant
Publication dateApr 23, 1974
Filing dateFeb 26, 1973
Priority dateFeb 26, 1973
Also published asCA1046372A1, DE2407652A1, DE2407652B2
Publication numberUS 3805767 A, US 3805767A, US-A-3805767, US3805767 A, US3805767A
InventorsErb R
Original AssigneeErb Rene
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Method and apparatus for non-surgical, reversible sterilization of females
US 3805767 A
Abstract
A method and apparatus is provided for non-surgical reversible sterilization of females. In the method of this invention an apparatus to which a removable tip is attached is inserted into the uterus. The tip is aligned with the uterine end of the oviduct. A curable elastomeric composition is injected, through an aperture in the tip, into the oviduct in an amount sufficient to fill the portion of the oviduct adjacent to the uterus. The elastomeric composition is allowed to solidify and adhere to the above noted tip. The apparatus is then removed with the tip being ejected from the apparatus so as to remain adhered to the resulting oviduct block. The above procedure is repeated for the opposite oviduct. The resulting oviduct blocks prevent the passage of ovum from the ovaries to the uterus and sperm from entering the oviduct thereby preventing conception. The oviduct blocks if desired can be removed non-surgically by utilizing an apparatus which grips the tip portion of the oviduct block and extracts the entire oviduct block from the oviduct.
Images(2)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent [191 Erb [1111 3,805,767 [451 Apr. 23, 1974 22 Filed:

[ METHOD AND APPARATUS FOR NON-SURGICAL, REVERSIBLE STERILIZATION OF FEMALES [76'1" liiviitdif Robert Allan Erb, PO. Box 86,

Valley Forge, Pa. 19481 4 Feb. 26, 1973 [21] Appl. No.: 335,816

[52] U.S. Cl....' 128/1 R, 128/130, 128/303 R [51] Int. Cl A6lb 19/00 [58] Field of Search 128/1 R, 2 R, 130, 303 R [56] References Cited UNITED STATES PATENTS 3.042.030 7/1962 Read ....'.1.2s/130x Cook et a1. 128/2 R Primary ExaminerDa1ton Truluck Attorney, Agent, or Firm-Edward J. Sites [57] ABSTRACT A method and apparatus is provided for non-surgical reversible sterilization of females. In the method of this invention an apparatus to which a removable tip is attached is inserted into the uterus. The tip is, aligned with the uterine end of the oviduct. A curable elastomeric composition is injected, through an aperture in the tip, into the oviduct in an amount sufficient to fill the portion of the oviduct adjacent to the uterus. The elastomeric composition is allowed to solidify and adhere to the above noted tip. The apparatus is then removed with the tip being ejected from the apparatus so as to remain adhered to the resulting oviduct block. The above procedure is repeated. for the opposite oviduct. The resulting oviduct blocks prevent the passage of ovum from the ovaries to the uterus and sperm from entering'the oviduct thereby preventing conception. The oviduct blocks if desired can be removed non-surgically by utilizing an apparatus whichgrips the tip portion of the oviduct block and extracts the entire oviduct block from the oviduct.

9 Claims, 5 Drawing Figures PATENTEDAPRB 1974 SHEET 1 [1F 2 METHOD AND APPARATUS FOR NON-SURGICAL, REVERSIBLE STERILIZATION OF FEMALES The invention described herein was reduced to practice in the course of work under a grant oraward from the Department of Health, Education and Welfare.

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is concerned with a method and apparatus for non-surgical, reversible sterilization of females.

2. Description of the Prior Art One of the more pressing problems which is encountered in the World today is that of over population. The problem of over population which has been a substantial problem for a considerable period of time in certain highly populated areas, such as Asia and the Indian Sub-Continent is now becoming a problem in less populated areas of the World such as Europe and the Americas. Over population results in such long range problems as pollution, famine and even war.

Birth control has been relied on as the principal means to control over-population. In the field of birth control the prevention of conception is considerably more acceptable for controlling population growth than abortion. However, the methods heretofore suggested for contraception have had certain inherent problems which limited the applicability and effectiveness,

The ideal contraception method should be 100 percent effective in preventing conception; should not rely on willpower; should not interfere with the satisfaction of sexual relationships, and should be low in cost taking into consideration the effective life of the contraceptive method. In addition the contraceptive method must not have any harmful psychological side effects. An extremely important feature of an ideal contraceptive method especially for family planning is that it be reversible so that it will be possible to have additional children if desired.

The most common methods of contraception which are currently employed on a mass scale each have certain inherent deficiencies which limit their usefulness. The use of such techniques and devices such as rhythm, withdrawal, condoms and diaphragms and vaginal foams all have been found to be highly unreliable. The more recently promoted methods such as intrauterine devices and use of contraceptive pills likewise have certain defects which limit their effectiveness. The intrauterine devices cannot be utilized by all females and there is some indication that they cause irritation and discomfort and are often rejected by females. The contraceptive pill cannot be utilized by many females due to incompatability with their normal hormone balance. Furthermore, the use of the pill has been found to increase the risks of certain carcigenic conditions.

There are currently two methods in wide use which are generally considered to be effective contraceptive methods. These are oviduct ligation for females and vasectomy for males In both these methods the ducts from the reproductive organs are severed and accordingly the contraceptive technique if properly performed and there is no natural regeneration are 100% effective. However, both methods have the defect that it is difficult, if not impossible, to reverse the procedure so as to restore the normal reproductive capacity.

It has been well established by gynecologists that a primary cause ofinfertility in females is blockage of the oviducts from the ovary to the uterus. The ovum when discharged from the ovaries is absorbed by the body and is prevented from coming in contact with the sperm and accordingly conception does occur. Females having this natural condition normally do not even realize it exists and do not suffer any adverse side effect besides being infertile. Having been made aware of this natural condition those skilled in the art have suggested artificial blocking of the oviduct to impart sterility.

It was reported by Corfman et al. in Obstetrices and Gynecology Vol. 27 No.6 pages 880-883 (June 1966) that various substances could be injected transcervically into the oviducts.

Hefnawi et al. Amr. J. Obst and Gynec, Vol. 99, No. 3 pages 421-427 (Oct. 1, 1967) reported attempts to block the oviducts by the injecting of medical grade elastomeric materials in the uncured state into the ovi ducts and allowing the material to solidify in the oviducts. The elastomeric material was thinned prior to injection so as to have a relatively fluid mixture for injection. The reported results obtained with rabbits was quite unsatisfactory. The incidence of pregnancy'after insertion of the oviduct blocks was quite high. Effective sterilization was only achieved if the plug was placed in I the medial portion of the oviduct. To remove the plug it was necessary to conduct laparotomy'. A further problem which was reported was the tendency for the plug to migrate from the oviduct into either the uterine cavity or even more dangerously into the peritoneal cavity. 7

Rakshit reported in the Calcutta Med J 65, No. 3. (Mar., 1968) attempts to use various materials to block the oviducts to prevent conception. It was suggested to use a plastic material of a nature which solidifies after being mixed with a catalyst to form the oviduct blocks. Rakshit specifically taught however that because of high viscosity the silicone rubbers could not be injected transvaginally and laparotomies were conducted to inject the material directly into the uterus. The material was then allowed to flow into the oviducts. It was suggested in this article by Rakshit that it may be possible to introduce a plastic material transcervically into the uterus and then to allow it to flow in the oviducts. Using this method however the resulting oviduct blocks would have to be removed surgically to reestablish fertility.

Rakshit further reported in Human Sterilization edited by Ralph Rechart (l97l) pages 213-221 the technique of attempting to form oviduct blocks by inserting a cannula directly into the uterus through the cervix and filling the uterus witha curable liquid silicone plastic. The injected silicone plastic was allowed to flow into the oviducts and cure in place to form the desired oviduct blocks. The excess material was then removed from the uterus. The reported results were not promising. On tests reported on 14 women there were nine satisfactory blockages, three doubtful cases and two negative cases. Further, in orderto remove the oviduct blocks it was necessary to conduct a laparotorny.

SUMMARY OF THE INVENTION In accordance with this invention a method and apparatus is provided to form oviduct blocks which prevent conception when in place and can be nonsurgically removed if desires. The apparatus is inserted through the cervical os into the uterus. The tip on the apparatus is then aligned with the uterine end of the oviduct. A mixture of a fluid elastomeric material and a catalyst for polymerizing the elastomeric mixture is injected through an aperture in the tip into the oviduct. The elastomeric material is allowed to solidify and to adhere to the tip. The tip is released so that it remains with the injected elastomeric material to form the oviduct block of this invention. The apparatus is then removed. The oviduct block can be removed nonsurgically by inserting an instrument into the uterus through the cervix which grips the tip of the oviduct block and then withdrawing the oviduct block which restores normal fertility.

BRIEF DESCRIPTION OF THE DRAWING FIG. 1 is an illustration in partial cross-section of an apparatus especially adopted for use in the method of this invention.

FIG. 2 is an illustration in partial cross-section of a uterus, the cervix and a portion of the vagina. The uterus is illustrated with an oviduct block insert in one of the oviduct and the terminal end of the apparatus of FIG. 1 positioned for insertion of an oviduct block into the opposite oviduct.

FIG. 3 is an enlarged illustration taken in partial cross-section of the terminal end of the apparatus of FIG. 1.

FIG. 4 is an illustration in cross-section of the terminal end of the apparatus of FIG. 3 shown with fluid uncured elastomeric material shown in the internal feed tube.

FIG. 5 is an illustration shown in cross-section showing the separation of the tip from the apparatus of FIG. 1.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In the method of this invention an oviduct block is formed in situ in the oviduct. The oviduct block is most preferable formed from a medical inert plastic which has approximately the same modulus of elasticity as the oviduct. The selection of material having the proper modulus of elasticity appears to both' prevent cxplusion of the oviduct block and substantially eliminates any physical discomfort. The materials which have been found most useful in the method of this invention are the commercially available medical grade silicone elastomers. The uncured silicone elastomer in the fluid state is blended with a catalyst for solidifying the elastomer and a dilution fluid to control the viscosity during injection and also to control the modulus of elasticity of the cured solidified material. It is preferable to also include a radiopaque material in the mixture to facilitate the placement of the oviduct block and to facilitate removal of the oviduct block if desires.

A tip is molded from an inert plastic material to which the injected elastomeric material will adhere on solidification. In this regard it should be noted that silicone-rubber is ideally suited for this purpose when a silicone elastomer is used for formation of the oviduct block. I

As shown in the drawing the portion of the tip 10 which will be in contact with uterine end of the oviduct 12 has a spherical configuration. The tip 10 has an aperture 14 which extends throughout the entire length of the tip 14. In addition the tip as illustrated has a-series of annular piston rings 16 molded into the interior portion surface of the aperture 14. The tip 10 further includes a loop 18 which is preferably a thread of a material which is inert in uterine fluids, such as nylon.

The apparatus 20 shown in FIG. 1 is specifically designed for use in the method of this invention. The apparatus 20 includes a tubular extension 22, a dispensing apparatus 24, and a control handle 26 for both operating the dispensing means and positioning the tip 10 on the end of the tubular extension 22.

The tubular extension 22 has a rigid section which is adjacent to the control handle 26. The opposite terminal end portion 28 on which the tip 10 is secured is flexible. One end of each control wire 30, 32 is attached to the end portion of the flexible section 28. The control wires 30, 32 are connected at their opposite ends to a pair of separately controlled drums 34 (only one drum is shown) mounted on the control hand 26. By adjustment of the drums 34 to either to collect or release the wires 30, 32 the position of the tip 10 can be adjusted and bent in a curved configuration shown in FIG. 2.

At the flexible terminal end 28 a metal connector 36 'is provided which has annular piston ring 38 which mates with the piston rings 16 on the tip 10. The metal connector '36 further has defined in it a constricted area having a sharp cut off portion 40.

A tube 42 extends from the dispensing means 24, through the tubular extension 22 to the aperture 14 in the tip 10.

The dispensing means 24 consists of a mixing syringe 44 in which the plunger 46 is adapted to provide mixing of a fluid elastermeric material, a catalyst and other additive as may be required. The syringe 44 is mounted on top of the control handle 26 with the plunger 46 in contact with a rack 48 and a pivotal mounted pawl 50. The pawl 50 is connected to a trigger 52. Squeezing the trigger 52 causes the plunger 46 to be advanced within the syringe 46 and material within thesyringe 44 to be dispensed through the tube 42 to the tip 10.

In the method of this invention the tip 10 is inserted over the end of the flexible portion 28 of the tubular extension. The tip 10 being premolded of asilicone rubher is somewhat elastic and deforms somewhat until the piston ring 16 of the tip of 10 engages and locks with the mating piston rings 38.

The tubular extension 20 with tip 10 installed is inserted into the vagina 54, through the cervical os 56 into the uterine cavity 58. Then, preferably using flouroscopic techniques, the tip 10 is aligned with the uterine end of one of the oviducts 12. It should be noted that because of the shape of the uterine cavity 58 thetip can be guided blindly in the proper position. The relative position of the flexible end 28 is controlled by adjustment of the drums 34.

Once the tip 10 is in position the fluid mixture of the elastomer, catalyst and other additives are injected through the tube 42 to the tip 10 by operation of the trigger 52 as noted above. The uncured fluid elastomeric mixture 60 flows through the aperture 14 in the tip 10 and then into the oviduct 12. A sufficient amount of the mixture is injected to fill approximately one third or more of the length of the oviduct 12. Some of the material will flow back around the tip 10 so that the surface of the tip 10 will conform to the shape of the uterine end of the oviduct 12 as shown in the tip 10 as modified 62 which is shown in FIG. 5.

stripped from the terminal end as shown in phantom in FIG. 5.

The procedure noted above is repeated for the opposite oviduct to complete the sterilization procedure.

The solidified oviduct blocks each has a configuration which conforms to the interior of the oviduct in which it is cast, thus effectively preventing conception.

The oviduct block can remain in place until it is desired to remove it. The use of a material having approximately the same modulus of elasticity as the oviducts assists in maintaining the oviduct blocks 64 in position. The natural convolution of the oviduct likewise results in stabilization of the oviduct blocks 64. The tip 10 serves a most important function of preventing the oviduct block 64 from migrating into the intraperitoneal cavity, a problem that was a serious and relatively common problem with othersimilar prior art technique.

As noted above the oviduct block is inserted nonsurgically. The method is relatively simple to learn by those skilled in the medical art. The time required is likewise quite short with a skilled person being able to block both oviducts in about 15 to 30 minutes.

As noted above the oviduct block can be removed nonsurgically if desired. An instrument of the type shown in FIG. 1 is used for this purpose. The tip 10 is replaced with a hooked member which is adapted to engage the loop 18. Once the loop 18 is engaged the oviduct block 64 is withdrawn. It is also possible to use a pronged member to grip the tip and then pull out the oviduct block.

Both the insertion and removal of the oviduct block 64 are relatively painless. However a local anesthetic can be used if desired.

The effectiveness of the contraception method of this invention was found to be excellent. On rabbit tests it was found that the method is 100% effective if the oviduct blocks are properly placed. In further rabbit tests it was found that after the oviduct blocks were removed that fertility was restored. There was no indication of explusion of the oviduct blocks either in the uterine cavity or in the int'raperitoneal cavity. Histologic examv, ination and scanning election microscopic examination have not indicated that there is any adverse reaction to the tissue of the oviducts.

The apparatus of this invention has been described in preferred embodiment. It should be appreciated that the various modifications can be made. to the apparatus without departing from'the scope of this invention. For

example, the control handle 26 has been provided to sisting of the trigger 52, rack 48 and pawl 50, could likewise be removed and the syringe operated manually. Furthermore, the configuration of the tip 10 can be modified to a different shape such as a conical configuration of other suitable shapes and still be satisfactory for use in this invention. These and other modifications which would be obvious to those skilled in the art are included within the scope of the subjoined claims.

I claim: 1. The method of forming non-surgically removable oviduct block in a female comprising the step of a. providing a shaped tip member having an aperture defined therein; said tip memlber having a configuration such as to fit in substantial sealing contact adjacent to the uterine end of the oviduct of said female, and having a size larger than the lumen of said oviduct; said tip member being formed from a given cured elastomeric material b. positioning said tip member within the uterine cavity of said female adjacent to the uterine end of said oviduct with the aperture of said tip member being in axial alignment with the lumen of said oviduct c. injecting through the aperture of said tip member into the lumen of said oviduct a mixture of a fluid self curing elastomeric material which will solidify in said oviduct and adhere to said tip member, said elastomeric material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity d. and thereafter allowing said uncured elastomeric material to cure to a solidified mass while in contact with said tip member whereby an oviduct block is formed wherein the tip member remains within the uterine cavity where it can be gripped by mechanical means to remove the oviduct block non-surgically.

2. The method according to claim 1 wherein said tip member further includes a loop member whereby said loop member can be gripped to non-surgically remove said oviduct block.

3. The method according to claim 1 wherein said selfcuring elastomeric material is a self-curing silicone elastomer. y

4. The method according to claim 1 wherein said selfcuring elastomeric material when solidified has a modulus of elasticity substantially the same as said oviduct.

5. The apparatus for forming the oviduct block according to claim 1, said apparatus comprising: a tubular means of a length sufficient to extend from vagina area of said female to the uterine ends of said oviducts and having a diameter sufficiently small to pass through the cervix of said female; said tubular means having first and second terminal ends; said first terminal end having an apertured tip member detachably connected thereto and also means for releaseably holding and ejecting said tip member, said tubular member including means for positioning said first terminal end with said tip member thereon adjacent the uterine end of said oviduct, and said tubular member further including means for transmission of said self curing elastomeric material from a point adjacent to the second terminal end toand through said aperture in said 'tip member secured to the first terminal end.

6. The apparatus of claim 5 in which the first terminal end portion is flexible. 1

7. The apparatus according to claim 5 in which the position of the first terminal end is controlled by means operable from the second terminal end.

from said slideable member.

9. The apparatus according to claim 5 wherein the dispensing means is a syringe having a barrel and a plunger and wherein the plunger is advanceable within the barrel by a rack and paw] drive operated from the second terminal end.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3042030 *Nov 25, 1958Jul 3, 1962Read ThaneSpherical type insert plug for body passageway and tool therefor
US3182662 *Jul 25, 1962May 11, 1965Shirodkar Vithal NPlastic prosthesis useful in gynaecological surgery
US3422813 *Jun 21, 1965Jan 21, 1969Dow CorningMethod for sterilization of males
US3648683 *Jun 29, 1970Mar 14, 1972Brodie NathanReversible intra-vas device
US3680542 *May 11, 1970Aug 1, 1972Cimber Hugo SDevice for occlusion of an oviduct
US3707146 *Mar 7, 1967Dec 26, 1972Prod Res & Chem CorpMeans to inject a plastic into a cavity to produce a replica thereof
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3871374 *Sep 6, 1973Mar 18, 1975Population Res IncDispensing instrument
US3875939 *Jan 31, 1974Apr 8, 1975Population Res IncSingle stroke dispensing method
US3918431 *Jan 11, 1974Nov 11, 1975Sinnreich ManfredFallopian tube obturating device
US3948259 *Mar 15, 1974Apr 6, 1976Population Research IncorporatedDispensing instrument
US3972331 *Jan 24, 1975Aug 3, 1976Population Research IncorporatedDispensing catheter
US4245623 *Jun 6, 1978Jan 20, 1981Erb Robert AMethod and apparatus for the hysteroscopic non-surgical sterilization of females
US4271845 *Jul 2, 1979Jun 9, 1981Kabushiki Kaisha Medos KenkyushoDevice for bending a medical instrument inserted into the body cavity
US4273131 *Jun 18, 1979Jun 16, 1981Auburn Enterprises, Inc.Surgical stylet
US4363318 *Jul 30, 1981Dec 14, 1982University Patents, Inc.Custom valved cervical cap
US4365632 *Dec 12, 1979Dec 28, 1982Kortum William MMethod and apparatus for inducing immunological and resistant response in mammary glands
US4446578 *Mar 8, 1982May 8, 1984Perkins Ezra CJoint treatment
US4601698 *Sep 17, 1984Jul 22, 1986Moulding Jr Thomas SMethod of and instrument for injecting a fluid into a uterine cavity and for dispersing the fluid into the fallopian tubes
US4637818 *Nov 18, 1985Jan 20, 1987Johnson Richard KApparatus for producing sterility in female animals
US4700701 *Oct 23, 1985Oct 20, 1987Montaldi David HSterilization method and apparatus
US4805618 *Apr 11, 1988Feb 21, 1989Olympus Optical Co., Ltd.Oviduct closing apparatus
US5217466 *Apr 19, 1991Jun 8, 1993Hasson Harrith MGuide for facilitating the performance of internal surgery
US5342394 *Nov 20, 1992Aug 30, 1994Olympus Optical Co., Ltd.Apparatus for blocking a vein branch and method of blocking a vein branch
US5368598 *Jun 7, 1993Nov 29, 1994Hasson; Harrith M.Method of manipulating an uterus using a bendable manipulator
US5555896 *Sep 22, 1995Sep 17, 1996Cimber; HugoIntrauterine contraceptive device
US5795353 *Nov 2, 1996Aug 18, 1998Advanced Bio Surfaces, Inc.Joint resurfacing system
US5954715 *Apr 20, 1998Sep 21, 1999Adiana, Inc.Method and apparatus for tubal occlusion
US6068626 *Aug 10, 1999May 30, 2000Adiana, Inc.Method and apparatus for tubal occlusion
US6145505 *May 28, 1999Nov 14, 2000Conceptus, Inc.Electrically affixed transcervical fallopian tube occlusion devices
US6176240Jun 7, 1995Jan 23, 2001Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6346102May 26, 2000Feb 12, 2002Adiana, Inc.Method and apparatus for tubal occlusion
US6526979Jun 12, 2000Mar 4, 2003Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US6634361Jun 1, 1999Oct 21, 2003Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US6679266Mar 28, 2002Jan 20, 2004Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6684884Jul 23, 2001Feb 3, 2004Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US6705323Jun 8, 1998Mar 16, 2004Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US6709667Aug 22, 2000Mar 23, 2004Conceptus, Inc.Easy, fast and reliable insertion and engagement
US6712810Mar 16, 2001Mar 30, 2004Adiana, Inc.Method and apparatus for tubal occlusion
US6726682Feb 12, 2002Apr 27, 2004Adiana, Inc.Method and apparatus for tubal occlusion
US6763833Aug 22, 2000Jul 20, 2004Conceptus, Inc.Insertion/deployment catheter system for intrafallopian contraception
US6871650 *Jun 12, 2000Mar 29, 2005Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US7001431Feb 13, 2003Feb 21, 2006Disc Dynamics, Inc.Intervertebral disc prosthesis
US7077865Feb 13, 2003Jul 18, 2006Disc Dynamics, Inc.Method of making an intervertebral disc prosthesis
US7220259Apr 26, 2004May 22, 2007Adiana, Inc.Method and apparatus for tubal occlusion
US7237552Jul 15, 2004Jul 3, 2007Conceptus, Inc.Insertion/deployment catheter system for intrafallopian contraception
US7428904May 14, 2004Sep 30, 2008Alien Technology CorporationContraceptive transcervical fallopian tube occlusion devices and their delivery
US7506650Feb 23, 2004Mar 24, 2009Conceptus, Inc.Deployment actuation system for intrafallopian contraception
US7582085Aug 24, 2004Sep 1, 2009Cytyc CorporationCatheter placement detection system and operator interface
US7591268Jun 15, 2005Sep 22, 2009Conceptus, Inc.Deployment actuation system for intrafallopian contraception
US7621276Aug 23, 2007Nov 24, 2009Yale UniversityIntrauterine fallopian tube occlusion device
US7669601Feb 15, 2006Mar 2, 2010Tal Michael GIntrauterine fallopian tube occlusion device and method for use
US7686020Aug 31, 2006Mar 30, 2010Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US7713301Mar 29, 2006May 11, 2010Disc Dynamics, Inc.Intervertebral disc prosthesis
US7766965Jun 30, 2006Aug 3, 2010Disc Dynamics, Inc.Method of making an intervertebral disc prosthesis
US7771357Jun 10, 2003Aug 10, 2010Vascular Control Systems, Inc.Devices and methods for occlusion of the uterine arteries
US7842035Mar 29, 2004Nov 30, 2010Cytyc CorporationMethod and apparatus for tubal occlusion
US7905880May 22, 2007Mar 15, 2011Cytyc CorporationMethod and apparatus for tubal occlusion
US7921848Aug 13, 2003Apr 12, 2011Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US7934504Jul 21, 2009May 3, 2011Conceptus, Inc.Deployment actuation system for intrafallopian contraception
US7975697May 11, 2006Jul 12, 2011Conceptus, Inc.Methods and apparatus for occluding reproductive tracts to effect contraception
US8048086Feb 24, 2005Nov 1, 2011Femasys Inc.Methods and devices for conduit occlusion
US8048101Sep 29, 2008Nov 1, 2011Femasys Inc.Methods and devices for conduit occlusion
US8052669Sep 29, 2008Nov 8, 2011Femasys Inc.Methods and devices for delivery of compositions to conduits
US8066007Jul 31, 2006Nov 29, 2011Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US8079364Mar 28, 2011Dec 20, 2011Conceptus, Inc.Deployment actuation system for intrafallopian contraception
US8100129Aug 28, 2007Jan 24, 2012Conceptus, Inc.Methods and devices for occluding an ovarian pathway
US8171936Oct 20, 2010May 8, 2012Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US8181653Jan 14, 2009May 22, 2012Yale UniversityIntrauterine fallopian tube occlusion device
US8217219Dec 29, 2003Jul 10, 2012Kimberly-Clark Worldwide, Inc.Anatomically conforming vaginal insert
US8226645Oct 26, 2010Jul 24, 2012Cytyc CorporationApparatus for tubal occlusion
US8231619Jan 22, 2010Jul 31, 2012Cytyc CorporationSterilization device and method
US8316853Jul 17, 2009Nov 27, 2012Femasys Inc.Method and devices for conduit occlusion
US8316854Oct 31, 2011Nov 27, 2012Femasys Inc.Methods and devices for conduit occlusion
US8324193Oct 31, 2011Dec 4, 2012Femasys Inc.Methods and devices for delivery of compositions to conduits
US8327852Nov 11, 2011Dec 11, 2012Conceptus, Inc.Occlusion devices and methods
US8336552Oct 31, 2011Dec 25, 2012Femasys Inc.Methods and devices for conduit occlusion
US8356599Nov 11, 2011Jan 22, 2013Conceptus, Inc.Occlusion devices and methods
US8381733Nov 11, 2011Feb 26, 2013Conceptus, Inc.Deployment actuation system
US8506543Jun 11, 2012Aug 13, 2013Kimberly-Clark Worldwide, Inc.Anatomically conforming vaginal insert
US8550085Jun 30, 2011Oct 8, 2013Conceptus, Inc.Methods and apparatus for occluding reproductive tracts to effect contraception
US8550086May 4, 2010Oct 8, 2013Hologic, Inc.Radiopaque implant
US8584679Feb 8, 2012Nov 19, 2013Conceptus, Inc.Deployment actuation system
US8613282May 7, 2012Dec 24, 2013Conceptus, Inc.Occlusion devices and methods
US8662081Aug 16, 2010Mar 4, 2014Yale UniversityIntrauterine device
US8695604May 10, 2012Apr 15, 2014Bayer Essure Inc.Deployment actuation system
US8695606Nov 24, 2012Apr 15, 2014Femasys Inc.Methods and devices for conduit occlusion
US8702727Nov 22, 2006Apr 22, 2014Hologic, Inc.Delivery catheter with implant ejection mechanism
US8726905Jan 20, 2012May 20, 2014Bayer Essure Inc.Methods and devices for occluding an ovarian pathway
US8726906Nov 25, 2012May 20, 2014Femasys Inc.Methods and devices for conduit occlusion
US8733360Aug 20, 2012May 27, 2014Bayer Essure Inc.Occlusion devices and methods
US8733361Nov 19, 2012May 27, 2014Bayer Essure Inc.Occlusion devices and methods
EP0010812A1 *Oct 26, 1979May 14, 1980Karel Johan Hendrik VerschoofContraceptive device
EP0891757A2 *Jul 17, 1998Jan 20, 1999Gynecare, Inc.Tubular fallopian sterilization device
EP1366729A2 *May 21, 1996Dec 3, 2003Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
EP1541101A2Sep 23, 1998Jun 15, 2005Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices
EP1561427A1May 21, 1996Aug 10, 2005Conceptus, Inc.Electrically expandable contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
EP2260800A2Sep 23, 1998Dec 15, 2010Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices
WO1996040023A1 *May 21, 1996Dec 19, 1996Conceptus IncContraceptive transcervical fallopian tube occlusion devices and their delivery
WO1996040024A1 *May 21, 1996Dec 19, 1996Conceptus IncContraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
WO1998055046A1Apr 20, 1998Dec 10, 1998Adiana IncMethod and apparatus for tubal occlusion
WO1999015116A1Sep 23, 1998Apr 1, 1999Conceptus IncContraceptive transcervical fallopian tube occlusion devices and methods
WO2000033724A2 *Nov 24, 1999Jun 15, 2000Hysterx IncDevices and methods for occlusion of the uterine arteries
Classifications
U.S. Classification128/831, 606/135, 128/840
International ClassificationA61F6/00, A61B19/00, A61F6/22
Cooperative ClassificationA61F6/225
European ClassificationA61F6/22B
Legal Events
DateCodeEventDescription
Jul 1, 1987AS02Assignment of assignor's interest
Owner name: CALSPAN CORPORATION, AN OH CORP.
Owner name: FRANKLIN INSTITUTE, 20TH STREET AND THE PARKWAY, P
Effective date: 19860604
Jul 1, 1987ASAssignment
Owner name: FRANKLIN INSTITUTE, 20TH STREET AND THE PARKWAY, P
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:CALSPAN CORPORATION, AN OH CORP.;REEL/FRAME:004747/0260
Effective date: 19860604
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CALSPAN CORPORATION, AN OH CORP.;REEL/FRAME:004747/0260
Owner name: FRANKLIN INSTITUTE, PENNSYLVANIA
Mar 7, 1985ASAssignment
Owner name: CALSPAN CORPORATION, 4455 GENESSE ST., BUFFALO, NY
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:FRANKLIN INSTITUTE;REEL/FRAME:004379/0744
Effective date: 19850109